跳至主要内容
临床试验/NCT05485337
NCT05485337已完成不适用

Effectiveness of Therapeutic Tactics of Analgesia in Patients With Gunshot and Mine-explosive Wounds at the Stages of Treatment

Bogomolets National Medical University1 个研究点 分布在 1 个国家目标入组 2,215 人开始时间: 2022年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,215
试验地点
1
主要终点
Didier Bouhassiraa DN4

研究概览

简要总结

In 82.1% of patients with gunshot and mine-explosive wounds, pain becomes chronic, therefore, the study of the effectiveness of therapeutic tactics for pain relief in this category of patients at the stages of treatment will be important for improving the results of pain treatment.

详细描述

The effectiveness of the therapeutic tactics of analgesia in patients with gunshot and mine-explosive wounds at the stages of treatment needs to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have their own characteristics. Given that in 82.1% of cases it is not possible to achieve a positive result of treatment, the data of our study will play an important role in their treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
Male
接受健康志愿者

入选标准

  • the presence of gunshot wounds

排除标准

  • no gunshot wounds

结局指标

主要结局

Didier Bouhassiraa DN4

时间窗: 12 months

4 or more points (a neuropathic pain component is present)

visual analog scale

时间窗: 12 months

from 0 to 10 points

Chaban Quality of Life Scale

时间窗: 12 months

up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high

The Hospital Anxiety and Depression Scale

时间窗: 12 months

0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity

Mississippi PTSD scale (military version)

时间窗: 12 months

the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vasyl' Horoshko

Chief researcher

Bogomolets National Medical University

研究点 (1)

Loading locations...

相似试验